IndustryCompany release

Windward Bio closes $251.2M IPO and private placement, with underwriters' option exercised in full

Windward Bio Group AG · Mon 16 Nov 2026

Swiss clinical-stage biotech Windward Bio Group AG closed its Nasdaq IPO of 11,838,234 common shares at $17.00 each. The total includes the underwriters' full option of 1,544,117 shares. Gross proceeds, including a concurrent private placement, were about $251.2 million. Shares began trading on the Nasdaq Global Select Market as WWB on November 13, 2026. Windward is developing ultra-long-acting antibodies for respiratory and dermatologic diseases.

Company's press release: Windward Bio Group AG ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →